Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Dianthus Therapeutics, Inc. /DE/ (DNTH) Insider Trading

3 open-market trades reported since Aug 19, 2026: 0 purchases worth $0 and 3 sales worth $4.81M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Edward CarrCAO0$01$2.03MSep 18, 2026
Simrat RandhawaEVP0$01$2.46MSep 3, 2026
Simon ReadDirector0$01$327KAug 19, 2026

All trades

DNTH insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 18Sep 17Edward CarrCAOCAO▼ SELL10b5-120,000101.38$2.03MAll soldForm 4 ↗
Sep 3Sep 1Simrat RandhawaEVPEVP▼ SELL10b5-123,124106.41$2.46M−85%Form 4 ↗
Aug 19Aug 19Simon ReadDirectorDirector▼ SELL10b5-12,778117.55$327KAll soldForm 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings